REPORT From the Basic Science Review Work Group National Institute on Drug Abuse May 2006 National Institute on Drug Abuse Division of Basic Neuroscience.

Slides:



Advertisements
Similar presentations
Janet Spoonamore, PhD UNCLASSIFIED / FOR OFFICIAL USE ONLY Mathematics Careers: Army Research Laboratory – Army Research Office.
Advertisements

Presented by: Jerry Legge Associate Provost for Academic Planning (Interim), and Professor of Public Administration and Policy (SPIA) Provost Advisory.
Mentors and Mentees: Resources for Investigators at MUSC Marc I. Chimowitz, MB,ChB Professor of Neurology Associate Dean of Faculty Development MUSC.
The Graduate School Research, Training and Innovation Interim Dean Dwayne Godwin, PhD Biomedical Sciences.
What’s NIH? National Cancer Institute National Eye Institute National Heart, Lung, and Blood Inst. National Human Genome Research Inst National Institute.
0 Research Center Membership Enrollment Forum November 26, 2007.
Peer Assessment of 5-year Performance ARS National Program 301: Plant, Microbial and Insect Genetic Resources, Genomics and Genetic Improvement Summary.
Defining Goals and Expectations: Program Leaders Kimberly Kerstann, Ph.D. and Paula Vertino, Ph.D. Winship Cancer Institute Emory University Atlanta, GA.
Diversity Assessment and Planning with members of the October 14, 2005.
NIH Brown Bag Lunch SOT 2010 March 9, 2010 Janice Allen, PhD Michael Humble, PhD Division of Extramural Research and Training (DERT) National Institute.
Career Development in Translational Addiction Research
Director’s Report to the National Advisory Council on Drug Abuse Director’s Report to the National Advisory Council on Drug Abuse February 8, 2006.
Special Projects Fiscal 2012 Activities. Overview Cross-cutting Issues that Guide Special Projects Cross-cutting Issues that Guide Special Projects Special.
Leadership in Psychology TERENCE M. KEANE, PH.D. Associate Chief of Staff for Research VA Boston Healthcare System Professor of Psychiatry & Psychology.
©Kuwait Foundation for the Advancement of Sciences Possibilities. Potential. Progress. Global Research Council Annual Meeting MENA Region Representative.
Creating Our Future: UConn’s Path to Excellence Open Forum March 26, 2014.
Lis Nielsen, Ph.D. Division of Behavioral and Social Research (BSR) National Institute on Aging NIA/IPSR Workshop: Advancing Integrative.
EMU Strategic Planning Strategic Planning Material Mission/Vision/Values Goals and Objectives January 10, 2014.
NIH Roadmap for Medical Research and Common Fund Update on Recent Changes Dinah Singer, Ph.D. Director, Division of Cancer Biology June 18, 2008.
Jacques Normand, Ph.D. Director, AIDS Research Program National Institute on Drug Abuse NIDA’s New HIV/AIDS Research Program.
February 3, Strategic Planning Update University Senate February 3, 2003.
REPORT The National Advisory Council on Drug Abuse Work Group On NIDA’s Approach to Grant-Making May 2006 The National Institute on Drug Abuse.
Director’s Report to the National Advisory Council on Drug Abuse Director’s Report to the National Advisory Council on Drug Abuse May 17, 2006.
Overview of NIDA Funding Opportunities and Grant Funding Tips Bethany Griffin Deeds, Ph.D., M.A. Deputy Chief, Epidemiology Research Branch Division of.
National Science Foundation 1 Evaluating the EHR Portfolio Judith A. Ramaley Assistant Director Education and Human Resources.
Research Program Overview National Institute on Disability and Rehabilitation Research Robert J. Jaeger, Ph.D. Interagency and International Affairs Interagency.
Presented by Maria Luz Fernandez, PhD (Diversity Committee Chair) to the University Senate March 2, 2015.
The Need for Training on Team and Meeting Management to Enhance Capacity for Team Science Kady Nearing, Senior Evaluator The Evaluation Center Colorado.
Update on the NIDA Intramural Program. We have recruited Dr. Elliot Stein as Chief, Neuroimaging Research Branch who is introducing fMRI into the existing.
TJPTSA DIVERSITY COMMITTEE MEETING NOVEMBER 10, 2010.
Federally Qualified Health Centers (FQHCs): Addressing the Challenges of Health Care Reform Community Treatment Program (CTP) Caucus Clinical Trials Network.
6 Key Priorities A “scorecard” for each of the 5 above priorities with end of 2009 deliverables – with a space beside each for a check mark (i.e. complete)
Susan R. Kayar, PhD Health Scientist Administrator Research Infrastructure NCRR, NIH Funding Opportunities through the National Center for Research Resources.
Archived File The file below has been archived for historical reference purposes only. The content and links are no longer maintained and may be outdated.
NAS/IOM Review of Rare Diseases Research and Orphan Products Development - USA Timothy Cote, M.D., MPH Director, Office of Orphan Products Development.
The Search for a “Better Way:” Reauthorization of the National Institutes of Health Elias A. Zerhouni, M.D., Director, NIH July 19, 2005 House Energy and.
NIDA Health Services Research Task Force Report and Recommendations Charge to Task Force  Dissemination of research findings to practice  Utilization.
Marguerite Littleton Kearney, PhD, RN, FAAN Director, Division of Extramural Science, NINR NIH/NINR Funding Opportunities in Family Health Research CANS.
REPORT OF THE NAGMS COUNCIL MORE DIVISION WORKING GROUP Charge to the Group The National Advisory General Medical Sciences (NAGMS) Council MORE Division.
John Holcomb, MD, FACS UTHSC-Houston The National Problem  Lack of centralized, organized infrastructure to guide the direction of study and dispersal.
NIAMS Training Grant and Career Development Award Program Evaluation Presented by David Wofsy, M.D. Chairman Evaluation Working Group September 27, 2007.
WASS Peer Review What are the next steps? Alfons Oude Lansink.
Bay Mills Community College Aaron Tadgerson Recruitment/Retention and Land Grant Development Coordinator.
Research in the Office of Vaccines Research and Review: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation and Research.
WASS Peer Review What are the next steps? Alfons Oude Lansink.
BIO AC November 18, 2004 Broadening the Participation of Underrepresented Groups in Science.
Update from the Division of Epidemiology, Services and Prevention Research Wilson M. Compton, M.D., M.P.E. Director, Division of Epidemiology, Services.
Archived File The file below has been archived for historical reference purposes only. The content and links are no longer maintained and may be outdated.
Realignment Task Force October 15, Charge to Committee “… studying possible realignment of faculty from the Departments of Anatomy, Pharmacology.
Approach to Grant-Making Work Group Preliminary Recommendations National Institute on Drug Abuse National Advisory Council February 8, 2006.
The evaluator point of view…. “IDEAS, ERC Starting Grant 2007” Henriette Molinari Department of Biotechnology University of Verona.
June 13, BRIEF NOTES ON METEOROLOGICAL ACTIVITIES AT THE EAST AFRICAN COMMUNITY PRESENTATION BY JOHN MUNGAI SENIOR METEOROLOGIST EAC.
UT System Employee Advisory Council Presentation by UTPA Representatives Teresa R. Garcia Velinda V. Reyes.
Research Directions and Update from the NIA Basil Eldadah Division of Geriatrics and Clinical Gerontology NIA.
DIVISION OF NEUROSCIENCE AND BEHAVIORAL RESEARCH (DNBR) NATIONAL ADVISORY COUNCIL ON DRUG ABUSE FEBRUARY 14, 2001 NIDA NATIONAL INSTITUTE ON DRUG ABUSE.
Peer Review and Grant Mechanisms at NIH What is Changing? May 2016 Richard Nakamura, Ph.D., Director Center for Scientific Review.
One Care of SWVA A Consortium of Substance Abuse Coalitions Sarah T. Melton, PharmD,BCACP,BCPP, FASCP Chair, One Care
David M. Murray, Ph.D. Associate Director for Prevention Director, Office of Disease Prevention Multilevel Intervention Research Methodology September.
Science for Global Health: Fostering International Research Collaboration James Herrington, PhD, MPH Director Division of International Relations Fogarty.
Building Community through Inclusive Excellence
Research Strategic Plan
International Relations Sector and IR-ECO Group
Bay Mills Community College
Special Projects Fiscal 2012 Activities.
Department of Medicine Michael Farkouh, Vice-Chair Research michael
ACTSI Presentation to MSCR Coloquium
UKCRC Translational Infection Research Initiative
Promotion on the Clinician Educator and Clinical Practice Tracks
Quality and Process Improvement Program (QPIP)
Minnesota State University, Mankato
Presentation transcript:

REPORT From the Basic Science Review Work Group National Institute on Drug Abuse May 2006 National Institute on Drug Abuse Division of Basic Neuroscience and Behavioral Research

NIDA Basic Science Review Work Group NIDA Basic Science Review Work Group Linda Porrino, Ph.D, Chair Barry Lester, Ph.D. John P. Rice, Ph.D. Guy Cabral, Ph.D. Frank Ivy Carroll, Ph.D Kathryn Cunningham, Ph.D Yasmin Hurd, Ph.D. Michael Nader, Ph.D. Marina Picciotto, Ph.D. Stanley Watson, M.D., Ph.D. First Meeting November 17-18, 2005 Second Meeting March 8-9, 2006 NIDA Council MembersOther Members

NIDA Basic Science Review Work Group  Review of the current Basic Science program portfolio  Recommendations to strengthen the current program  Input into the 5-year plan for NIDA’s Basic Science program with an emphasis on: –Genetic vulnerability and protection –Epigenetics (interactions of environment and genetics) –The genetics and neurobiology of social behavior –Molecular biology of addiction  Examination of the organization and management of DBNBR and its interactions with other NIDA Divisions/Centers Charge: To produce a written report that includes…

Review Findings  Cross-cutting findings and recommendations  Theme-specific findings and recommendations –Processes and mechanisms of addiction –Genetic vulnerability to drug abuse –Pain and analgesia –AIDS, HCV, virology –Development –Chemistry and medicinal chemistry –Social neuroscience

Cross-cutting Findings: Accomplishments  Exceptionally strong and forward thinking portfolio  Recruitment of excellent scientists in and outside the field of substance abuse  Strong leadership and staff  Ability to identify new areas of importance to NIDA and recruit a critical mass to the area  Training of new investigators  Efforts to increase gender and minority diversity  Thematic approach that cuts across branches

Cross-cutting Findings: Opportunities  Encouraging translation across NIDA Divisions –Formation of a Task Force on Translational Addiction Research –Assignment of grants to program staff of more than one Division –Formation of an Innovation Committee made of up of representatives from each Division to provide support for potential high payoff applications beyond the pay line  Focus on development of improved animal models with greater predictive value  Improve dissemination of information about NIDA services  Continue efforts to encourage grantees to utilize Roadmap and Blueprint funding mechanisms

Theme-Specific Findings: Accomplishments  Establishment of the NIDA Genetics Consortium and the studies utilizing these resources  Expanding studies across the life span: Addition of studies in adolescence to the development portfolio  Development of programs in the area of lipidomics  Program for the distribution of drugs and other materials  Basic science studies of virology and immunology  Continued development of animal models that better mimic various aspects of the human drug experience

Theme-Specific Findings: Opportunities  Addition of neurobiology of social behavior as a thematic area with an emphasis on genetics and epigenetic studies  Further emphasis on developmental studies through the establishment of a Developmental Research Program in the Office of the Director  Expanded emphasis on the Genetics Consortium  Continued emphasis on HIV/AIDS, particularly animal models and interactions beyond opioids  Continued emphasis on the development of safe and effective pain medications

Conclusions/Summary  DBNBR has established strong research programs central to the mission of NIDA: to bring the power of science to bear on problems of drug abuse.  DBNBR plays a critical role in translation of basic science conducted in their division to studies of human patients conducted in other NIDA divisions  Opportunities to enhance basic science include: –Investment in emerging areas of social neuroscience and epigenetics –Strengthened dissemination of services –Continued fostering of the careers of new investigators –Continued emphasis on the “revolution” in the ways science will be conducted in the future